Ofatumumab (OFA) Maintenance Prolongs PFS in Relapsed CLL: Prolong Study Interim Analysis Results

Category Primary study
JournalBlood
Year 2014
This article has no abstract
Epistemonikos ID: da476b2908c77893be4c6aa1abe32a1198eea7c3
First added on: Feb 19, 2025